13F Insight
DOSSIER · 13F Holders · Q1 2026
NEUP

NEUPHORIA THERAPEUTICS IN

18 institutions still hold NEUPHORIA THERAPEUTICS IN as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 64136E102·18 13F holders·last filed Mar 31, 2026
Market cap
—
13F value held
$7M
visible holders
Holders
18
filers reporting
Concentration
52.68%
Lynx1 Capital Management LP #1
top holder share
AI Holders Summary · Q1 2026

18 institutions reported NEUP in Q1 2026. Lynx1 Capital Management LP leads at 52.7% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Lynx1 Capital Management LP
CIK 0001910456
$4M875K0.56%Q1 202602
AdvisorShares Investments LLC
CIK 0001425930
$632K155K0.12%Q1 202603
Shay Capital LLC
CIK 0001723643
$615K151K0.05%Q1 202604
BALYASNY ASSET MANAGEMENT L.P.
CIK 0001218710
$579K142K0.00%Q1 202605
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$401K99K0.00%Q1 202606
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$212K52K0.00%Q1 202607
Ikarian Capital, LLC
CIK 0001778253
$193K47K0.02%Q1 202608
VANGUARD FIDUCIARY TRUST CO
CIK 0000933478· Index
$137K34K0.00%Q1 202609
ADAR1 Capital Management, LLC
CIK 0001940272
$122K30K0.01%Q1 202610
FNY Investment Advisers, LLC
CIK 0001742998
$107K27K0.05%Q1 202611
BOOTHBAY FUND MANAGEMENT, LLC
CIK 0001549230
$57K14K0.00%Q1 202612
Virtu Financial LLC
CIK 0001533964· Market maker
$49K12K0.00%Q1 202613
COMMONWEALTH EQUITY SERVICES, LLC
CIK 0000312272
$46K11K0.00%Q1 202614
Merck & Co., Inc.
CIK 0000310158
$41K10K0.01%Q1 202615
UBS Group AG
CIK 0001610520
$9K2K0.00%Q1 202616
RHUMBLINE ADVISERS
CIK 0001115418
$8222020.00%Q1 202617
MORGAN STANLEY
CIK 0000895421
$236580.00%Q1 202618
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025
Insiders at NEUPHORIA THERAPEUTICS IN
Papapetropoulos Spyros →Davies Peter Miles Winston →Ryan Jane →Wilson David Ian →Fisher Alan →